Harmenberg U - Search Results

1

Tumour markers in gastrointestinal cancer.

Wahren B, Harmenberg U. Wahren B, et al. Among authors: harmenberg u. Scand J Clin Lab Invest Suppl. 1991;206:21-7. doi: 10.3109/00365519109107722. Scand J Clin Lab Invest Suppl. 1991. PMID: 1947757 Review. No abstract available.

2

Clinical relevance of tumour markers CA 19-9 and CA-50 in sera from patients with pancreatic duct carcinoma.

Von Rosen A, Linder S, Harmenberg U, Wiechel KL. Von Rosen A, et al. Among authors: harmenberg u. Surg Oncol. 1992 Apr;1(2):109-13. doi: 10.1016/0960-7404(92)90023-e. Surg Oncol. 1992. PMID: 1341241

3

Search for epitopic sites of antibodies to germ cell alkaline phosphatase.

Harmenberg U, Ljungdahl-Ståhle E, Rudén U, Wahren B. Harmenberg U, et al. Cancer Commun. 1991;3(10-11):305-11. doi: 10.3727/095535491820873759. Cancer Commun. 1991. PMID: 1722106

4

Identification and characterization of alkaline phosphatase isozymes in human colorectal adenocarcinomas.

Harmenberg U, Koha M, Makiya R, Koshida K, Brismar B, Stigbrand T, Wahren B. Harmenberg U, et al. Tumour Biol. 1991;12(4):237-48. doi: 10.1159/000217710. Tumour Biol. 1991. PMID: 1871513

5

Significance of alkaline phosphatase isozymes in the monitoring of patients with colorectal carcinoma.

Harmenberg U, Frödin JE, Ljungdahl-Stähle E, Mellstedt H, Wahren B, Stigbrand T. Harmenberg U, et al. Tumour Biol. 1989;10(5):225-31. doi: 10.1159/000217619. Tumour Biol. 1989. PMID: 2814231

6

Clinical effects of monoclonal antibodies (MAb 17-1A) in patients with metastatic colorectal carcinomas.

Frödin JE, Harmenberg U, Biberfeld P, Christensson B, Lefvert AK, Rieger A, Shetye J, Wahren B, Mellstedt H. Frödin JE, et al. Among authors: harmenberg u. Hybridoma. 1988 Aug;7(4):309-21. doi: 10.1089/hyb.1988.7.309. Hybridoma. 1988. PMID: 3262566

7

Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract.

Harmenberg U, Wahren B, Wiechel KL. Harmenberg U, et al. Cancer Res. 1988 Apr 1;48(7):1985-8. Cancer Res. 1988. PMID: 3349472

8

Polyclonal and monoclonal anti-CEA antibodies in immunolocalization of colorectal cancer.

Wahren B, Hammarström S, Harmenberg U, von Krusenstierna S, Larsson SA, Lundell G, Rudén U, Schnell PO. Wahren B, et al. Among authors: harmenberg u. Tumour Biol. 1986;7(5-6):361-9. Tumour Biol. 1986. PMID: 3495029

9

Improved radioimmunolocalization of carcinomas using Fab fragments with anti-CEA specificity.

Ljungdahl-Ståhle E, Harmenberg U, Rudén U, Hammarström S, Stigbrand T, Wahren B. Ljungdahl-Ståhle E, et al. Among authors: harmenberg u. Tumour Biol. 1986;7(5-6):353-60. Tumour Biol. 1986. PMID: 3576081

10

Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma.

Mosolits S, Harmenberg U, Rudén U, Ohman L, Nilsson B, Wahren B, Fagerberg J, Mellstedt H. Mosolits S, et al. Among authors: harmenberg u. Cancer Immunol Immunother. 1999 Feb;47(6):315-20. doi: 10.1007/s002620050536. Cancer Immunol Immunother. 1999. PMID: 10203061 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters